The c-MYB proto-oncogene encodes a transcription factor which plays an
important role in hematopoiesis. We detected truncated c-MYB mRNA (2.
0 kb) and c-Myb protein (55 kDa) in the TK-6 cell line, which was esta
blished from a patient with chronic myelogenous leukemia in T cell bla
st crisis. Mutated c-MYB cDNA clone (WTK-1) was isolated from a TK-6 c
ell cDNA library and sequenced in its entirety. Compared with the wild
type human c-MYB sequence, the WTK-1 sequence diverged at the 3' ends
of exons 9. A termination codon was present as the second codon downst
ream from the point of divergence and was followed by a previously unk
nown rearranged sequence. The conceptual protein encoded by WTK-1 (Myb
(TK-6)) comprises 402 amino acids and lacks the negative regulatory do
main of the normal c-Myb, reminiscent of the activated form of Myb pro
tein. Luciferase reporter assay in NIH3T3 cells showed that the expres
sion vector encoding Myb(TK-6) stimulated Myb-regulated mim-1 promoter
more effectively than that encoding wild-type human c-Myb, suggesting
that Myb(TK-6) is functional as a transcription factor, and thus as a
potential transforming protein. Southern blot and mutant allele-speci
fic polymerase chain reaction analyses showed that the same rearrangem
ent of the c-MYB gene in TK-6 was present in late, but not in early, s
pecimens obtained from the patient, indicating that this mutation had
been acquired during disease progression.